Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RABEPRAZOLE vs RAMUCIRUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RABEPRAZOLE vs RAMUCIRUMAB: Safety Overview

Metric RABEPRAZOLE RAMUCIRUMAB
Total FAERS Reports 11,416 5,357
Deaths Reported 1,676 1,444
Death Rate 14.7% 27.0%
Hospitalizations 2,143 2,066
Average Patient Age 55.7 yrs 63.9 yrs
% Female Patients 71.0% 33.0%
FDA Approval Date Apr 24, 2018 N/A
Manufacturer A-S Medication Solutions Eli Lilly and Company
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription